Pulmonary hypertension--advances in medical and surgical interventions.
McLaughlin
V V
VV
Rush Heart Institute, Center for Pulmonary Heart Disease, Chicago, Ill, USA.
Rich
S
S
D000925:Anticoagulants / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D011464:Epoprostenol / Q000627:therapeutic use; D006331:Heart Diseases / Q000150:complications; D016041:Heart-Lung Transplantation; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology / Q000628:therapy*; D011655:Pulmonary Embolism / Q000150:complications; D012595:Scleroderma, Systemic / Q000150:complications
D000925:Anticoagulants; D002121:Calcium Channel Blockers; D011464:Epoprostenol